Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background & Aims</h3><p>PreS mutants of HBV have been reported to be associated with hepatocellular carcinoma (HCC). We conducted a longitudinal study of the role of HBV preS mutations on development of HCC, particularly in chronic hepatitis B (CHB) patients having low HBV DNA or ALT levels, and investigated effects of secretion‐defective preS2 deletion mutant (preS2ΔMT) on hepatocyte damage <i>in vitro</i> and liver fibrosis <i>in vivo</i>. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Approach and Results</h3><p>Association of preS mutations with HCC in 343 CHB patients was evaluated by retrospective case‐control follow‐up study. Effects of preS2ΔMT on HBsAg retention, ER stress, calcium accumulation, mitochondrial dysfunction, and liver fibrosis were examined. Multivariate analysis revealed significant association of preS mutations with HCC (HR: 3.210, 95% CI: 1.072‐9.613; p=0.037) including cases with low HBV DNA or ALT levels (HR: 2.790, 95% CI: 1.133‐6.873; p=0.026). Antiviral therapy reduced HCC risk, including cases with preS mutations. preS2ΔMT expression promoted HBsAg retention in ER and unfolded protein response (UPR). TEM examination, MitoTracker staining, real‐time ATP assay, and calcium staining of preS2ΔMT‐expressing cells revealed aberrant ER and mitochondrial ultrastructure, reduction of mitochondrial membrane potential and ATP production, and calcium overload. Serum HBV secretion levels were ~100‐fold lower in preS2ΔMT‐infected hu‐FRG mice than in WT HBV‐infected mice. preS2ΔMT‐infected mice displayed upregulation of UPR and caspase‐3, and enhanced liver fibrosis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>PreS mutations were significantly associated with HCC development in CHB patients, including those low HBV DNA or ALT levels. Antiviral therapy reduced HCC occurrence in CHB patients, including those with preS mutations. Intracellular accumulation of mutated HBsAg induced or promoted ER stress, calcium overload, mitochondrial dysfunction, impaired energy metabolism, liver fibrosis, and HCC.</p></section>

The Strategy of Conditionally Replicating Adenovirus-Mediated PreS2 Mini-Antibody Expression Has Dual Effects of Inhibiting HBV Infection and Preventing Hepatocellular Carcinoma.

An Anti-Pres2 Antibody Protects Human Hepatocytes From Hepatitis B Virus Infection

Adenoviral Vector Encoding the Whole Humanized Antibody Gene of Pres_2 Antigen Inhibiting the Recurrence of Hepatitis B Virus after Liver Transplantation

Immune therapeutical effect induced by inoculation with recombinant plasmid encoding preS/S antigen in HBV DNA transgenic mice

Construction of hepatocellular specific preS2 antisense RNA expression vector and study of its inhibitory effect

In Vitro Transfection Of The Hepatitis B Virus Pres2 Gene Into The Human Hepatocarcinoma Cell Line Hepg2 Induces Upregulation Of Human Telomerase Reverse Transcriptase

INHIBITION OF HEPATITIS B VIRUS BY COMBINED Sirnas IN VITRO

[Impact of Different Adjuvants on Immunogenicity of the HBV Particle Vaccine Containing the S + Pres1 Fusion Antigen in Balb/C Mice].

Inhibition of in Vivo Growth of Gepatoma Cells by Antisense Phosphorothioate Oligodeoxynucleotides Complementary to the Initiator of HBV Pre-S2

PreS1BP mediates inhibition of Hepatitis B virus replication by promoting HBx protein degradation

Antiviral effects of recombinant adenovirus AdMxA in vitro on HBV

Inhibition of Hepatitis B Virus by Small Interfering RNA Expressed from Adenovirus-associated Virus Vectors

Vaccines Targeting PreS1 Domain Overcome Immune Tolerance in HBV Carrier Mice

Inhibitory Effects of Vector-Based Sirna Targeting S Gene on Hepatitis B Virus Gene Expression in HepG2 2.2.15 Cells

A Virus-Like Particle of the Hepatitis B Virus Pres Antigen Elicits Robust Neutralizing Antibodies and T Cell Responses in Mice.

Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo.

HBV Pres Mutations Promote Hepatocarcinogenesis by Inducing Endoplasmic Reticulum Stress and Up-Regulating Inflammatory Signaling

HBV preS Mutations Promote Hepatocarcinogenesis by Inducing Endoplasmic Reticulum Stress and Upregulating Inflammatory Signaling

Adeno-Associated Virus Vector-Mediated Sirna Inhibition Of Hepatitis B Virus Gene Expression In Vitro

Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development

[Transfection of Sirna Expressing Plasmids Targeting S Gene Inhibits Replication and Expression of Hepatitis B Virus in Hepatic Cancer Cells].